ArticleScientific reports2026
A cell-laden methacrylated chitosan-based photocrosslinkable hydrogel for bone tissue engineering and its in vitro structural and biological characterization.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Chitosan-Based Adhesive Composite Hydrogel to Provide Antibacterial and Anti-Inflammatory Properties for Biomedical Application.Gels (Basel, Switzerland) · 2026Article
- Black phosphorus-loaded mineralized UV-responsive chitosan hydrogel for enhanced osteogenesis and antibacterial activity.Regenerative biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The treatment of extensive bone defects involves the use of multicomponent scaffolds where different components can be precisely controlled according to specific conditions. Therefore, hybridizing biomaterials within cell-laden osteogenic bioscaffolds provides promising opportunities for clinical applications. In this study, a cell-laden, photocrosslinkable hydrogels composed of methacrylated chitosan (MECs) and silk fibroin (SF) fibers was developed to induce osteogenesis, and its structural and biological properties was investigated. SF fibers were mineralized with a hydroxyapatite (HAp) layer using a modified alternate soaking followed by heat treatment. Optimal photocrosslinking conditions were determined using the Taguchi method. SF fibers were incorporated into MECs at varying concentrations, and the resulting hydrogel structure was assessed with and without fibers under different ionic conditions. Adipose-derived stem cells (ADSCs) were encapsulated into hydrogels, and their morphology, viability, and osteogenic gene expression were analyzed. FTIR, XRD, and SEM confirmed successful mineralization of SF, with heat treatment enhancing HAp crystallinity. SF addition effectively prevented hydrogel shrinkage and promoted a porous structure due to fiber enrichment and double crosslinking. Encapsulated ADSCs remained viable after 14 days, and mineralized fibers significantly upregulated bone-related gene expression compared to controls. This study introduces a biomimetic, fiber-enriched, osteoinductive hydrogel with strong potential for the repair and regeneration of large bone defects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.